A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

NCT00501696 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: 4.5 mg Naltrexone
DRUG: Naltrexone

Sponsor

University of California, San Francisco